Plasmapheresis Versus Intravenous Immunoglobulin in Patients With Autoimmune Neuromuscular and Neuro-immunological Conditions [0.03%]
自身免疫性神经肌肉和神經免疫疾病患者血浆置换与静脉注射丙种球蛋白的对比研究
Adeel S Zubair,Melissa Rethana,Anthony Ma et al.
Adeel S Zubair et al.
Objectives: Plasmapheresis (PLEX) and intravenous immunoglobulin (IVIg) are commonly used to treat autoimmune neuromuscular disorders, including myasthenia gravis, acute inflammatory demyelinating polyradiculoneuropathy, ...
Guillain-Barré Syndrome and COVID-19 Vaccine: A Multicenter Retrospective Study of 46 Cases [0.03%]
Guillain-Barré综合征与新冠疫苗：46例多中心回顾性研究
Juan Ignacio Castiglione,José Manuel Crespo,Mariana Bendersky et al.
Juan Ignacio Castiglione et al.
In the context of the global vaccination campaign against COVID-19, several cases of postvaccinal Guillain-Barré syndrome (GBS) were reported. Whether a causal relationship exists between these events has yet to be established. We investig...
Attitudes and Beliefs Toward Thymectomy in the Myasthenia Gravis Patient Registry [0.03%]
重症肌无力患者登记库中胸腺切除术的态度及信念
Ali G Hamedani,Tarrant O McPherson,Inmaculada Aban et al.
Ali G Hamedani et al.
Objectives: To evaluate patient attitudes and beliefs toward thymectomy for myasthenia gravis (MG). Methods: The Myasthenia Gravis Foun...
Clenbuterol Treatment Is Safe and Associated With Slowed Disease Progression in a Small Open-Label Trial in Patients With Amyotrophic Lateral Sclerosis [0.03%]
克仑特罗治疗的安全性及其在肌萎缩侧索硬化症患者中的延缓疾病进展作用：一项小规模开放标签试验的结果
Xiaoyan Li,Dwight D Koeberl,Michael W Lutz et al.
Xiaoyan Li et al.
Objective: Clenbuterol, a beta-agonist, has plausible mechanisms for treating amyotrophic lateral sclerosis (ALS). In this highly inclusive open-label trial (NCT04245709), we aimed to study the safety and efficacy of clen...
Rapid Conversion to a Completely Virtual Multidisciplinary ALS Clinic in Response to the COVID-19 Pandemic: Implications for Future Care Delivery [0.03%]
新冠肺炎疫情期间快速转换为完全虚拟的多学科ALS门诊及其对未来护理方式的影响
James Grogan,Susan Walsh,Anne Haulman et al.
James Grogan et al.
Objectives: The goals of this study were to assess the feasibility of maintaining multidisciplinary remote care, patient preferences, and outcomes of this transition because of COVID-19. ...
Greater Number of Plasma Exchanges Does Not Improve Outcome in Myasthenic Crisis [0.03%]
重症肌无力危象患者血浆置换治疗的疗效与置换次数无关
Michael Hansen,Lee Neilson,Melanie Parikh et al.
Michael Hansen et al.
Objectives: To determine the relationship between the number of plasma exchanges and clinical outcome in patients experiencing myasthenic crisis. Methods:...
Neonatal Fc Receptor Inhibitor Therapeutics in Neuromuscular Disease [0.03%]
neonatal fc受体抑制剂在神经肌肉疾病中的治疗作用
Mustafa Jaffry,Daniel L Menkes,Anam Shaikh et al.
Mustafa Jaffry et al.
The Neonatal Fc Receptor (FcRn) is integral to a wide variety of processes including IgG recycling, serum albumin turnover, and bacterial opsonization. Thus, targeting FcRn will increase antibody degradation including pathogenic IgGs. FcRn ...
DMD Gene and Dystrophinopathy Phenotypes Associated With Mutations: A Systematic Review for Clinicians [0.03%]
杜氏肌营养不良基因及与突变相关的表型：临床医生的系统性综述
Jennifer G Andrews,Maureen Kelly Galindo,Shiny Thomas et al.
Jennifer G Andrews et al.
The diagnosis of Duchenne and Becker muscular dystrophy (DBMD) is made by genetic testing in approximately 95% of cases. Although specific mutations can be associated with skeletal muscle phenotype, pulmonary and cardiac comorbidities (lead...
Small-Fiber Neuropathy After Vaccination With mRNA-1273 SARS-CoV-2 Vaccine [0.03%]
mRNA-1273 SARS-CoV-2疫苗接种后的小纤维神经病
James H Bernheimer,Baohan Pan,Bonnie J Gerecke
James H Bernheimer